SPRY4-mediated ERK1/2 signaling inhibition abolishes 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell

References

• Shing Y, Folkman J, Sullivan R, et al. Heparin-affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (Washington DC) 1984;223:1296–8
   PubMed Web of Science ®Google Scholar
• Soulitzis N, Karyotis I, Delakas D, Spandidos DA. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. Int J Oncol 2006;29:305–14
   PubMed Web of Science ®Google Scholar
• Soufla G, Sifakis S, Baritaki S, et al. VEGF, FGF2, TGFB1 and TGFBR1 mRNA expression levels correlate with the malignant transformation of the uterine cervix. Cancer Lett 2005;221:105–8
   PubMed Web of Science ®Google Scholar
• Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends Mol Med 2002;8:483–9
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Plotnikov AN, Ibrahimi OA, et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 2000;6:743–50
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994;369:156–60
   PubMed Web of Science ®Google Scholar
• Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001;22:153–83
   PubMed Web of Science ®Google Scholar
• Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179–85
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhao X, Yan L, Li M. Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway. Gynecol Oncol 2011;122:669–74
   Google Scholar
• Hacohen N, Kramer S, Sutherland D, et al. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 1998;92:253–63
   PubMed Web of Science ®Google Scholar
• Macdonald SG, Crews CM, Wu L, et al. Reconstitution of the Raf-1–MEK–ERK signal transduction pathway in vitro. Mol Cell Biol 1993;13:6615–20
   PubMed Web of Science ®Google Scholar
• Ballif BA, Blenis J. Molecular mechanisms mediating mammalian mitogenactivated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 2001;12:397–408
   PubMedGoogle Scholar
• Hanafusa H, Torii S, Yasunaga T, et al. Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty. J Biol Chem 2004;279:22992–5
   PubMed Web of Science ®Google Scholar
• Sasaki A, Taketomi T, Kato R, et al. Mammalian SPRY4 suppresses Ras-independent ERK activation by binding to Raf1. Nat Cell Biol 2003;5:427–32
   PubMed Web of Science ®Google Scholar
• Yusoff P, Lao DH, Ong SH, et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 2002;277:3195–201
   PubMed Web of Science ®Google Scholar
• Bundschu K, Walter U, Schuh K. The VASP-Spred-Sprouty domain puzzle. J Biol Chem 2006;281:36477–81
   Google Scholar
• Billottet C, Elkhatib N, Thiery JP, Jouanneau J. Targets of fibroblast growth factor 1 (FGF-1) and FGF-2 signaling involved in the invasive and tumourigenic behavior of carcinoma cells. Mol Biol Cell 2004;15:4725–34
   PubMed Web of Science ®Google Scholar
• Ferriani RA, Charnock-Jones DS, Prentice A, et al. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod 1993;8:11–16
   PubMed Web of Science ®Google Scholar
• Zhang H, Guo Q, Wang C, et al. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estrodial-induced cell growth in endometrial adenocarcinoma cell. Mol Cell Endocrinol 2013;376:60–9
   Google Scholar
• Abulafia O, Triest WE, Sherer DM. Angiogenesis in malignancies of the female genital tract. Gynecol Oncol 1999;72:220–31
   PubMed Web of Science ®Google Scholar
• Wang J, Thompson B, Ren C, et al. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. Prostate 2006;66:613–24
   PubMed Web of Science ®Google Scholar
• Kwabi-Addo B, Wang J, Erdem H, et al. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 2004;64:4728–35
   PubMed Web of Science ®Google Scholar
• Fritzsche S, Kenzelmann M, Hoffmann MJ, et al. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma. Endocr Relat Cancer 2006;13:839–49
   PubMed Web of Science ®Google Scholar
• Lo TL, Yusoff P, Fong CW, et al. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 2004;64:6127–36
   PubMed Web of Science ®Google Scholar
• Faratian D, Sims AH, Mullen P, et al. Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy. PLoS One 2011;6:e23772
   PubMed Web of Science ®Google Scholar
• Velasco A, Pallares J, Santacana M, et al. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma. Hum Pathol 2011;42:185–93
   PubMed Web of Science ®Google Scholar
• Giavazzi R, Sennino B, Coltrini D, et al. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumour growth and angiogenesis. Am J Pathol 2003;162:1913–26
   PubMed Web of Science ®Google Scholar
• Hori A, Sasada R, Matsutani E, et al. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 1991;51:6180–4
   PubMed Web of Science ®Google Scholar
• Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999;401:173–7
   PubMed Web of Science ®Google Scholar
• Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007;26:3203–13
   PubMed Web of Science ®Google Scholar